Helus Pharma Inc. (NASDAQ:HELP)
| Market Cap | 662.61M+80.9% |
| Revenue (ttm) | 0 |
| Net Income | -183.27M-49.1% |
| EPS | -5.51+7.2% |
| Shares Out | 61.98M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 217,995.822 |
| Open | 10.08 |
| Previous Close | 10.19 |
| Day's Range | 10.06 - 10.72 |
| 52-Week Range | 3.76 - 15.15 |
| Beta | 0.54 |
| Analysts | Buy |
| Price Target | 22.00(+105.80%) |
| Earnings Date | Nov 12, 2026 |
Helus Pharma Inc. has a live Insider Score.
Scored on 9 qualifying trades from 4 insiders in the last 90 days.
About HELP
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$HELP stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in HELP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HELP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HELP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New HELP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HELP from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in HELP
| ETF | Est. Holding Size |
|---|---|
| PSILAdvisorShares Psychedelics ETF | $3.78M |
| ONEQFidelity Nasdaq Composite Index ETF | $326.54K |
| GWXState Street SPDR S&P International Small Cap ETF | $311.30K |
| QQQSInvesco NASDAQ Future Gen 200 ETF | $100.07K |
| TNXTT. Rowe Price Innovation Leaders ETF | $9.39K |
Estimated from each fund’s disclosed top holdings × AUM
HELP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from HELP’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score